Prof. Dr. Dennis Säring is a faculty member at the University of Applied Sciences Wedel , specifically affiliated with the School of Engineering. His academic and research activities focus on Deep Learning , Medical Image Analysis , and applications of Artificial Intelligence in healthcare and biomedical imaging. He has led seminars on Deep Learning topics and supervised student projects in Autonomous Driving at Audi's AADC 2018 competition. Research Highlights : Cardiovascular imaging, forensic age estimation via MRI, neural network-based bone segmentation, and cerebrovascular aneurysm analysis. Technical Expertise : Cardiac MRI, 3D/4D image processing, parametric mapping, and spatiotemporal data fusion. His recent publications (2018-2023) emphasize 3D MR segmentation for age assessment, CMR strain analysis in athletes, and T1/T2 mapping for myocarditis. Key collaborations include institutions like the University Medical Center Hamburg-Eppendorf and Wedler Hochschulbund, with funding for autonomous vehicle research. While no explicit scientific awards are listed, his work spans clinical cardiology, forensic radiology, and AI-driven medical diagnostics.
Alanson Sample is an Associate Professor in the Department of Electrical Engineering and Computer Science at the University of Michigan (since 2018), leading the Interactive Sensing and Computing Lab. His research focuses on Human-Computer Interaction, Cyber-Physical Systems, and wireless technology innovations. He holds a PhD in Electrical Engineering from the University of Washington (2011), with prior postdoctoral work there developing implantable medical devices. Before academia, Sample held senior roles at Disney Research (2013-2018) as Executive Lab Director and Principal Research Scientist, leading teams in Robotics, AI, Computer Vision, and HCI. Earlier, he worked at Intel Labs (2008-2013) on energy harvesting for wearables and IoT. Key research themes include wireless power systems, embedded sensing, and privacy-aware technologies. Over 150+ publications span topics like magnetic sensing (MagDesk), acoustic gesture recognition (HandSAW), and privacy-preserving activity tracking (PrivacyMic). His work bridges academic and industry innovation, particularly in scalable interactive systems and medical technology. Notable projects include the Quasistatic Cavity Resonance wireless charging system, RFID-based sensing platforms (WISP), and wearable health monitoring devices. His lab develops hardware-software co-design frameworks for energy-efficient embedded systems. Current research emphasizes medical applications, smart infrastructure, and ubiquitous computing interfaces.
Michael McAlpine is a Professor in the Mechanical Engineering department at the University of Minnesota . He also holds affiliations with the Biomedical Engineering and Electrical and Computer Engineering departments. His research focuses on 3D printing functional materials & devices , Nanoscale inks , Biomedical devices , Bioelectronics , and Flexible Microsystems . Research Interests : 3D Printing, Biomedical Engineering, Nanotechnology, Flexible Electronics, Microfluidics Labs : ME 361/363 Contact : mcalpine@umn.edu , (612) 626-3303, ME 117 Recent Research Trends include 3D Printed Biomedical Devices , Flexible Electronics , and Bioprinting Applications . His work spans from Spinal Organoid Formation to Programmable Drug Release Capsules . Scientific Award : Circulation Research 2020 Best Manuscript Award
James Briscoe is a Senior Group Leader at The Francis Crick Institute in London, where he leads a research group focused on developmental biology and morphogen signaling. He previously held positions at the Medical Research Council's National Institute for Medical Research, which later became part of the Francis Crick Institute. Education: BSc in Microbiology and Virology from the University of Warwick, UK PhD from Imperial Cancer Research Fund/King's College London Postdoctoral training at Columbia University with Thomas Jessell Dr. Briscoe's research focuses on the molecular and cellular mechanisms of graded signaling by morphogens and the role of transcriptional networks in cell fate specification. His laboratory employs a range of experimental and computational techniques using model systems including mouse and chick embryos and embryonic stem cells. His work has significant implications for understanding developmental processes and their relationship to disease. His recent publications demonstrate a continued focus on morphogen gradients, neural tube development, and computational approaches to understanding cell fate decisions. His research increasingly integrates single-cell technologies and computational modeling to unravel the complexities of developmental patterning. Scientific Awards and Honors: EMBO Young Investigator (2001) EMBO Gold Medal (2008) Elected to EMBO (2009) Fellow of the Academy of Medical Sciences (2019) Fellow of the Royal Society (2019) As Editor-in-Chief of the journal Development since 2018, Dr. Briscoe plays a significant role in shaping the field of developmental biology. His leadership extends to mentoring researchers and contributing to scientific policy discussions, as evidenced by his recent publication 'Science under siege: protecting scientific progress in turbulent times.' Dr. Briscoe's laboratory at the Crick Institute is well-equipped with access to advanced facilities including light microscopy, flow cytometry, genomics, and computational resources, enabling a multidisciplinary approach to developmental biology questions.
Holly J. Benjamin, MD is a distinguished sports medicine specialist at the University of Chicago, serving as the inaugural Director of the Primary Care Sports Medicine Program at UChicago Medicine Student Wellness Center. She holds leadership positions including Chair of the Committee on Sports Medicine & Fitness for the Illinois Chapter of the American Academy of Pediatrics, and serves as Head Medical Team Physician for the WNBA Chicago Sky and medical officer for major events including the Bank of America Chicago Marathon, US Soccer, and USA Triathlon. Her educational background includes: B.S. in Integrated Life Sciences, Kent State University (1994) Combined BS/MD, Northeastern Ohio Universities College of Medicine (1994) MD, Northeastern Ohio Universities College of Medicine (1994) Residency in Pediatrics, The University of Chicago Children's Hospital (1997) Fellowship in Primary Care Sports Medicine, Lutheran General Hospital (1998) Dr. Benjamin specializes in sports medicine with particular expertise in youth, adolescent, and collegiate athletes. Her research spans acute and overuse sports injuries, concussion management, sport biomechanics, and musculoskeletal ultrasound. She has made significant contributions to understanding injury prevention strategies, safe return-to-play protocols, and the psychological aspects of sports injuries. Her work frequently addresses female athletes and elite/professional athletes, with emphasis on evidence-based approaches to optimize performance while minimizing injury risk. Recent publications demonstrate a strong focus on concussion research, with multiple studies examining diagnostic approaches, recovery trajectories, and factors influencing outcomes. Her work spans biomechanics, mental health considerations in sports injuries, and innovative approaches to injury prevention across various athletic populations. Her scientific recognition includes: Election as Fellow of the American College of Sports Medicine (2003), becoming the second female pediatrician ever elected Election as Fellow of the American Medical Society of Sports Medicine Distinguished Alumni Award from The New Aurora High School Alumni (1999) Invitation to serve as volunteer physician for the Olympic Training Center (2008) Multiple expert contributions to national media including Runner's World and the Naperville Sun Dr. Benjamin actively mentors through her coaching roles at high school and collegiate levels, emphasizing safe return-to-play post-injury and injury prevention. She has developed educational content through video productions for the American Academy of Pediatrics and serves as head team physician for the University of Chicago Lab School and the NCAA Division III UChicago Maroons. Notably, she is one of only a few sports medicine specialists in the country offering diagnostic and procedural musculoskeletal ultrasound in her office, demonstrating her commitment to advanced diagnostic capabilities for patient care.
Nima Mesgarani is an Associate Professor of Electrical Engineering at Columbia Engineering, Columbia University, affiliated with the Sense, Collect and Move Data Committee. His research bridges engineering and neuroscience through reverse-engineering neural signal processing mechanisms, leading to advancements in brain-machine interfaces, neural prosthetics, and speech processing algorithms. He received his PhD in Electrical Engineering from the University of Maryland and completed postdoctoral training at Johns Hopkins University's Center for Language and Speech Processing and UC San Francisco's Neurosurgery Department. Research Focus Professor Mesgarani's lab integrates computational neuroscience and engineering to study acoustic signal processing. Key areas include: Neural decoding of speech and auditory attention in multi-talker environments Development of brain-controlled hearing technologies Novel speech separation and synthesis algorithms inspired by cortical processing Cross-modal learning between auditory and visual systems Applications of large language models in neural signal interpretation Publication Trends Analysis of his 15 most recent articles (2025) reveals dominant themes: neural decoding techniques using intracranial EEG, brain-inspired speech separation models (e.g., Mamba architectures), applications of large language models in auditory neuroscience, cross-modal distillation methods, and clinical translation of audio processing algorithms. A strong emphasis emerges on real-time brain-computer interfaces and noise-robust speech processing. Laboratory and Collaborations Mesgarani directs an interdisciplinary lab developing neurotechnology for hearing restoration. His team collaborates with neurosurgery departments and speech processing centers, focusing on translating theoretical models into clinical brain-machine interfaces. The lab's work has yielded patents for brain-informed speech separation systems and attention-decoding frameworks.
Professor Mark Coles serves as Professor of Immunology and Lead for Industrial Strategy and Entrepreneurship at the Kennedy Institute of Rheumatology, University of Oxford, holding concurrent roles as Kennedy Trust Senior Research Fellow, Official Fellow at Reuben College, and Affiliate Faculty at the Wolfson Centre of Mathematical Biology. His interdisciplinary work bridges immunology, computational modeling, and translational research to accelerate therapies for immune-mediated inflammatory diseases. His academic journey began with a BSc in Microbiology from Cornell University (1992), followed by a PhD in Molecular and Cell Biology at UC Berkeley under David Raulet, and postdoctoral training with Dimitris Kioussis at the National Institute of Medical Research. At the University of York (2006-2017), he pioneered stromal immunology research and co-founded the York Computational Immunology Laboratory. Coles' research centers on stromal and systems immunology, with core expertise in stromal cell biology, inflammatory disease mechanisms, and mathematical modeling of immune responses. He champions 3Rs-based approaches (Replacement, Reduction, Refinement) to reduce animal testing through in silico models, integrating spatial single-cell biology with multi-scale computational frameworks to dissect immune function in human tissues. His 2025 publications reveal a cohesive research trajectory applying interdisciplinary methods across diverse disease contexts—from cardiac fibrosis and vaccine responses to arthritis pathogenesis and CAR-T cell therapy—unified by focus on stromal-immune crosstalk and quantitative modeling to identify therapeutic targets. Key honors include: Fellow of the Royal Society of Biology Kennedy Trust Senior Research Fellow As former Director of Graduate Studies (2017-2024) at the Kennedy Institute, Coles mentored numerous graduate students while co-leading major initiatives including the Arthritis Therapy Acceleration Program and Human Cell Atlas medicalization. His entrepreneurial impact spans three co-founded ventures: Simomics Ltd (in silico disease modeling), Lightox Ltd (phototherapy for oral cancer), and Mestag Therapeutics (fibroblast-targeted therapies for cancer/inflammation). He directs the Laboratory of Stromal and Systems Immunology and Oxford Mathematical Immunology Group, fostering collaborations with Christopher Buckley, Calliope Dendrou, and Eamonn Gaffney to develop Quantitative Systems Pharmacology models that translate mechanistic insights into patient therapies.
Jakob Schoeffer is a tenure-track Assistant Professor in the Artificial Intelligence department at the Bernoulli Institute for Mathematics, Computer Science and Artificial Intelligence, Faculty of Science and Engineering, University of Groningen (Netherlands). His work focuses on the intersection of human decision-making and artificial intelligence, particularly in high-stakes contexts where fairness, transparency, and appropriate human-AI collaboration are critical. Dr. Schoeffer's research interests center on responsible and explainable AI, with specific focus areas including: Human-AI collaboration dynamics in decision-making processes Fairness perceptions and interventions in AI systems Appropriate reliance on AI recommendations Explainable AI techniques for high-stakes domains Transparency mechanisms that improve human-AI team performance Label indeterminacy issues in medical AI applications His recent publications (2023-2025) reveal a strong trend toward applying AI research in critical domains like healthcare (particularly neurological recovery prediction), while maintaining a rigorous focus on the human aspects of AI deployment. His work spans both theoretical foundations of human-AI interaction and practical implementations, often employing mixed-methods approaches that combine technical AI development with behavioral studies. Dr. Schoeffer actively collaborates with researchers across institutions including the University of Texas at Austin and has made significant contributions to top conferences in AI ethics, fairness, and human-computer interaction. His research has been featured in multiple news outlets and policy discussions, indicating real-world impact of his work on responsible AI development. Prior to his current appointment, Dr. Schoeffer was a Postdoctoral Research Fellow at the University of Texas at Austin. He received his PhD from the Karlsruhe Institute of Technology (KIT) in Germany with a dissertation titled "On the Interplay of Transparency and Fairness in AI-Informed Decision-Making." He also holds a master's degree in Operations Research from Georgia Tech and industry experience as a Senior Data Scientist at IBM.
Owen R. White is a Professor in the Department of Epidemiology & Public Health at the University of Maryland School of Medicine, serving as Associate Director of the Institute for Genome Sciences and Associate Director of Research Collaboration & Development. He leads a team of 25 scientists and engineers developing genomic annotation pipelines and data analysis tools for state-of-the-art research in microbiome and multi-omic studies. His academic background includes: BS in Biotechnology from the University of Massachusetts (1985) PhD in Molecular Biology from New Mexico State University (1992) Postdoctoral Fellowship in Genome Informatics at the Institute for Genomic Research (TIGR) (1994) Dr. White's research spans bioinformatics, genomics, transcriptomics, and metagenomics with emphasis on data management, metadata standards, ontologies, and cloud systems. His work has been foundational for large-scale initiatives like the Human Microbiome Project (HMP) and Integrative Human Microbiome Project (iHMP), generating over 50,000 datasets totaling 10 terabytes of multi-omic data. Analysis of his recent publications reveals a strong trend toward neuroscience multi-omics (BRAIN Initiative), cloud-based data infrastructure, and ethical data sharing frameworks. His work consistently bridges microbiome research with emerging fields like single-cell analysis and Alzheimer's disease biomarker discovery through integrated data platforms. Notable awards include: Benjamin Franklin Award for Open Access in the Life Sciences (2015) Kumho Science International Award in Plant Molecular Biology and Biotechnology (2001) As Principal Investigator for major NIH-funded centers, he has secured sustained support for the HMP Data Analysis and Coordination Center and iHMP Data Coordination Center. His team's work combines fee-for-service models with collaborative research funding to maintain cutting-edge genomic analysis capabilities. The Institute for Genome Sciences houses his computational team responsible for developing production annotation pipelines, database systems, and visualization tools that serve researchers across the University of Maryland School of Medicine and national consortia.
Charles E. Leonard is an Associate Professor of Epidemiology at the Perelman School of Medicine , University of Pennsylvania. He holds affiliations with multiple Penn-based institutions, including the Center for Real-World Effectiveness and Safety of Therapeutics (CREST), Institute for Translational Medicine and Therapeutics, Leonard Davis Institute, Institute on Aging, and Center of Excellence in Environmental Toxicology. Additionally, he serves as a Special Government Employee at the FDA and Honorary Lecturer at Muhimbili University of Health and Allied Sciences in Tanzania. Pharmacoepidemiology Post-market prescription drug safety Causal inference methods Real-world evidence generation Environmental health impacts on chronic disease Dr. Leonard’s research focuses on generating real-world evidence to address critical gaps in drug safety, particularly for: Population health effects of drug interactions Comparative safety of antidiabetes drugs Drug-induced sudden cardiac arrest Ambient temperature extremes and chronic disease Pharmacoepidemiology methods development His work is primarily funded by the National Institutes of Health (NIH) and has been recognized through multiple awards, including the 2024 Harold I. Feldman Distinguished Scholar Award and the 2020 Elected Fellow status at the International Society for Pharmacoepidemiology. He also contributes to curriculum development and student mentoring in Penn’s Graduate Group in Epidemiology and Biostatistics. 2024 – Harold I. Feldman Distinguished Scholar Award (Penn) 2024 – Ronald D. Mann Best Paper Award (ISPE) 2020 – Leadership Medallion (BPS) 2019 – Abraham G. Hartzema Distinguished Lecturer (University of Florida)
Huining Li is an Assistant Professor in the Department of Computer Science at North Carolina State University . Her research focuses on Internet of Things (IoT) , cybersecurity , and mobile computing , with a specialized emphasis on mobile health (mHealth) technologies. Education: Ph.D. in Computer Science and Engineering from University at Buffalo (2024). Her work addresses privacy-preserving sensing mechanisms , biomarker measurement , and fairness in dynamic mobile environments , developing systems for chronic wound care, Parkinson’s disease management, and mental health therapy. Recent publications highlight innovations in mmWave biometrics , machine learning for health diagnostics , and non-contact monitoring . Scientific Awards: Best Paper Awards (SenSys 2019, BodyNet 2021, ICHI 2022) Best Paper Candidate (SenSys 2022) Harold O. Wolf Achievement Award (2024) EECS Rising Star (2023) NIH mHealth Training Institute Scholar (2025) She teaches courses in Mobile Health Systems and Applications and Computer Networks , and actively serves on NSF panels , TPC committees (ACM MobiSys, IEEE-EMBS BSN), and as Associate Editor for journals like Elsevier Smart Health.
Professor Carlo Pappone is a Full Professor of Cardiology at Vita-Salute San Raffaele University (since 2019) and Director of the Arrhythmology Department at IRCCS Policlinico San Donato Hospital (since 2015). He has held previous academic/clinical leadership roles at IRCCS San Raffaele Hospital (2000-2010), Villa Maria Cecilia Hospital (2010-2015), and University of Naples Federico II (1990-2000). With 212 publications in top journals like NEJM, JAMA, and Circulation, he has made significant contributions to cardiac arrhythmia research. Current Positions Vita-Salute San Raffaele University (2019-present): Full Professor of Cardiology IRCCS Policlinico San Donato Hospital (2015-present): Director of Arrhythmology Department Previous Roles University of Naples Federico II (1990-2000) University of Michigan Ann Harbor (1990-2000) IRCCS San Raffaele Hospital (2000-2010) Villa Maria Cecilia Hospital (2010-2015) Research Focus: Specializing in cardiovascular diseases, his work spans atrial fibrillation ablation techniques, Brugada syndrome pathogenesis, heart failure device therapy, and ion channel disorders. His H-index of 53 and 18,407 citations reflect his substantial academic impact. Notable Scientific Contributions Author of 44 patents Principal Investigator in 14 clinical trials (clinicaltrials.gov) Developed circumferential pulmonary vein ablation technique Innovator in biventricular pacing systems for heart failure Pioneered research on non-excitatory current for cardiac contractility Scientific Recognition Awarded as Elite Reviewer of JACC (2005) Editorial Board Member of 6 leading journals Reviewer for NEJM, JAMA, Lancet, and Nature Medicine Education Medical Doctorate: University of Naples Federico II
David S. Eisenberg is a Professor of Chemistry and Biochemistry and Biological Chemistry at the University of California, Los Angeles, where he also serves as Director of the UCLA-DOE Institute for Genomics and Proteomics and as an HHMI Investigator. His research focuses on protein interactions, particularly the structural basis for conversion of normal proteins to the amyloid state and conversion of prions to the infectious state. Dr. Eisenberg earned his undergraduate degree in biochemical sciences from Harvard College and his D.Phil. degree in theoretical chemistry from Oxford University on a Rhodes Scholarship. His postdoctoral research was on ice and water with Walter Kauzmann at Princeton and in protein crystallography with Richard Dickerson. He joined the UCLA faculty after his postdoctoral studies. Dr. Eisenberg and his research group focus on protein interactions in amyloid and prion diseases. These diseases involve protein aggregation where normal functional proteins convert to abnormal aggregated forms. Systemic amyloid diseases like dialysis-related amyloidosis result from fiber accumulation until organ failure, while neurodegenerative diseases like Alzheimer's, Parkinson's, ALS, and prion conditions appear to be caused by smaller oligomers. In 2005, his team determined the atomic-level structure for the amyloid fiber spine, revealing a 'steric zipper' of two parallel beta sheets packed across a dry interface. Since then, they've determined approximately 90 amyloid spines from 15 disease-related proteins. In 2010, they identified the structure of a toxic amyloid-related oligomer consisting of six anti-parallel beta strands forming a cylindrical barrel. His recent publications demonstrate continued innovation in amyloid research, with focus areas including structural prediction of amyloid formation, mechanisms of tau fibril disassembly in Alzheimer's disease, cryo-EM analysis of amyloid polymorphism, and structure-based design of inhibitors for amyloid toxicity. His work integrates computational, structural, and biochemical approaches to understand protein aggregation across multiple disease contexts. Dr. Eisenberg has received numerous prestigious awards and honors: National Academy of Sciences Member American Philosophical Society Member Institute of Medicine Member Howard Hughes Medical Institute Investigator Biophysical Society Emily M. Gray Award Harvard Westheimer Medal UCLA Seaborg Medal Technion - Israel Institute of Technology Harvey Prize in Human Health As Director of the UCLA-DOE Institute for Genomics and Proteomics and an HHMI Investigator, Dr. Eisenberg leads significant research initiatives in protein structure and aggregation. His laboratory combines X-ray crystallography, bioinformatics, and biochemical techniques to investigate protein interactions, with particular emphasis on amyloid-forming proteins and their role in disease. The Eisenberg Lab, located in Boyer Hall at UCLA, maintains an active research program investigating the structural basis of protein aggregation. The lab continues to build on its landmark discoveries of amyloid structures while exploring new frontiers in understanding protein misfolding diseases and developing potential therapeutic interventions.
Professor Daniel Rueckert is a leading academic in Artificial Intelligence and Medical Imaging, holding dual positions at Imperial College London (as Professor of Visual Information Processing) and Technical University of Munich (Alexander von Humboldt Professor for AI in Medicine and Healthcare). He obtained his MSc from Technical University Berlin (1993) and PhD from Imperial College London (1997), followed by postdoctoral work at King’s College London. At Imperial, he led the Department of Computing (2016–2020) and founded the Biomedical Image Analysis group. His research focuses on AI-driven medical image analysis, including algorithms for image reconstruction, registration, and clinical decision support. His research interests span AI applications in healthcare, machine learning for medical imaging, and computational methods for clinical diagnostics. Notable contributions include over 500 publications and 60+ PhD graduates, with key works in federated learning, cardiac motion analysis, and biomarker development. Awards include the Leibniz Prize (2025), Royal Academy of Engineering Fellowship (2015), and multiple ERC grants. He leads the BioMedIA research group and is an editorial board member of Medical Image Analysis . Recent publications highlight advancements in AI-driven medical imaging, such as secure federated learning frameworks and deep learning models for disease prediction. His work bridges academic and industrial sectors through initiatives like IXICO, an Imperial spin-out. Current affiliations include roles at both Imperial and TUM, emphasizing interdisciplinary collaboration in healthcare technology. Advising and grants: Supervised over 60 PhD students and 40 post-docs. Secured grants including ERC Synergy (2013) and ERC Advanced (2020). Active in labs focused on biomedical image computing and AI in healthcare systems. Collaborative efforts include the BioMedIA group and TUM’s AI initiatives. Labs/teams: Leads the Biomedical Image Analysis group at Imperial and the TUM AI in Medicine team. Collaborates extensively on projects like cardiac imaging analysis and federated learning for healthcare.
Dr A. I. Shihab is a Senior Lecturer at Kingston University's Faculty of Engineering, Computing and the Environment, Department of Networks and Digital Media. He teaches programming languages (C++/Java), data structures, web development, and AI/machine learning. His research focuses on affective computing and machine learning applications including: Acoustic event detection in sports environments Audio signal analysis for tennis match modeling Multi-camera visual surveillance systems Medical imaging analysis using fuzzy clustering techniques Publications demonstrate expertise in combining audio/video modalities for sports analytics (tennis rallies, court-shots) and developing Markov models for sound event sequence analysis. Contact: a.shihab@kingston.ac.uk
